Home/Investors/Alta Partners

Alta Partners

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

7

Top Stage

Phase 1

Investment Focus

Rare Diseases Hematology Metabolic Disorders Oncology Respiratory Diseases Genetic Disorders Viral Infections

Portfolio Companies

Company	Stage	Valuation	Focus
Be Biopharma	Phase 1	—	Rare Diseases, Hematology
Edgewood Oncology	Phase 1	—	Oncology
Ethris	Pre-clinical	—	Respiratory Diseases, Genetic Disorders

Frequent Co-Investors

Atlas Venture2 shared ARCH Venture Partners1 shared Bristol Myers Squibb1 shared EcoR1 Capital1 shared Nextech Invest1 shared RA Capital Management1 shared Longwood Fund1 shared dievini Hopp BioTech holding1 shared